Sign in
4

Changes in Ownership

Immix Biopharma, Inc. Filed Acc 0001493152-21-032035

Chief Financial Officer bought 2,000 shares at $5.00 ($10,000)

  • Chief Financial Officer acquired 320,819 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Morris Gabriel S · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-20 Conversion : show line 1 in the form +74,116 $0.85 $62,999 74,116 D
2021-12-20 Conversion : show line 2 in the form +123,527 $0.85 $104,998 123,527 I
2021-12-20 Conversion : show line 3 in the form +123,176 $0.85 $104,700 246,703 I
2021-12-20 Purchase : show line 4 in the form +2,000 $5.00 $10,000 76,116 D
Open-market purchases · 2,000 sh · avg $5.00 · $10,000

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-12-20 Conversion : show line 5 in the form Convertible Note −0 0 D
2021-12-20 Conversion : show line 6 in the form Convertible Note −0 0 I
2021-12-20 Conversion : show line 7 in the form Convertible Note −0 0 I
Loading xslF345X03/ownership.xml…